Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517740 | SCV000614487 | uncertain significance | not specified | 2016-11-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002527506 | SCV003721090 | uncertain significance | Inborn genetic diseases | 2022-10-26 | criteria provided, single submitter | clinical testing | The c.1348C>A (p.P450T) alteration is located in exon 6 (coding exon 6) of the PKD1 gene. This alteration results from a C to A substitution at nucleotide position 1348, causing the proline (P) at amino acid position 450 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Department of Pathology and Laboratory Medicine, |
RCV005398739 | SCV006052491 | uncertain significance | Polycystic kidney disease, adult type | 2024-11-14 | criteria provided, single submitter | clinical testing |